Neutrophil Elastase Inhibitor (Sivelestat) in the Treatment of Acute Respiratory Distress Syndrome Induced by COVID- 19: A Multicenter Retrospective Cohort Study
Preprint in Research Square (February 2024)
The most recent citing publications are shown below. View all 90 publications that cite this research output on Dimensions.
Sivelestat in Patients at a High Risk of Postoperative Acute Lung Injury After Scheduled Cardiac Surgery: A Prospective Cohort Study.
Article in Journal of Inflammation Research (February 2024)
Neutrophil heterogeneity and aging: implications for COVID-19 and wound healing
Article in Frontiers in Immunology (November 2023)